Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

November 9, 2026 · 5:52 pm 3 sources

Image: MarketWatch

Coverage

Coverage

• Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
  MarketWatch · November 9, 2026 17:52
  Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.
• FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
  Ars Technica · November 10, 2026 14:43
  The risk appears small and data is mixed, but FDA wants patients to be aware.
• GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these medicines explains the potential side effect
  This article is republished from The Conversation under a Creative Commons license. Read the original article. · November 10, 2026 23:07
  Doctors often call the condition a stroke of the eye – and though the risk is small, patients should know the symptoms and seek immediate treatment if they occur.